Skip to main content
. Author manuscript; available in PMC: 2023 Aug 17.
Published in final edited form as: Eur J Epidemiol. 2017 Aug 30;32(12):1075–1088. doi: 10.1007/s10654-017-0299-y

Table 11.

Multivariate regression model to assess the relationship of gestational age at delivery (weeks) with fetal dose, restricted to individuals with data taken from medical records, or medical records and logs

Parameter estimate (+95% CI) 2-sided P value
Fetal dose (weeks/Gy)   0.787 (0.273, 1.426) 0.014
Trimester 1 versus trimester 3 −0.105 (−0.366, 0.149) 0.430
Trimester 2 versus trimester 3 −0.027 (−0.244, 0.198) 0.802
Parity ≥1 versus parity 0   0.175 (−0.034, 0.399) 0.110
Baby sex female versus baby sex male   0.018 (−0.179, 0.211) 0.855
Twin versus singleton −0.845 (−1.785, −0.090) 0.046
Maternal age (weeks/year) −0.017 (−0.045, 0.012) 0.281
Maternal height (weeks/cm)   0.009 (−0.011, 0.030) 0.577
Maternal weight at 1st clinic (weeks/kg)   0.015 (−0.004, 0.031) 0.075
Model with separate dose × trimester
  Dose in trimester 1 (weeks/Gy) 15.440 (4.421, 91.846) 0.566
  Dose in trimester 2 (weeks/Gy)   0.298 (−0.524, 1.078) 0.410
  Dose in trimester 3 (or missing) (weeks/Gy)   1.330 (0.560, 2.710) 0.036
Linear quadratic model in dose
  Linear dose (weeks/Gy)   2.210 (0.595, 3.790) 0.014
  Quadratic dose (weeks/Gy2) −1.423 (−2.836, −0.109) 0.028

All regressions evaluated using 4999 bootstrap resamples. Model adjusted for trimester of exposure, parity, baby’s sex, singleton/twin birth, maternal age at delivery of offspring, maternal height and maternal weight at first clinic visit. The estimates for the constant term and for indicators of covariate missingness are not given. Analysis of n = 1065 persons with non-missing data on gestational age and fetal dose, with data taken from medical records and/or logs